Takeda’s post-merger deals continue as OTC subsidiary is prepared for sale

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 7, 2020 at 8:42 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,013
    Likes Received:
    3
    via Takeda has been burdened under mountains of debt since acquiring Shire for $62 billion 18 months ago, but one of the company’s biggest moves yet to relieve the stress could be on the horizon.

    article source